NATCOPHARM — Natco Pharma Share News
0.000.00%
Last trade - 00:00- IN₹141.83bn
- IN₹120.26bn
- IN₹40.78bn
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees
Brief: Natco Pharma Approves Rights Issue Of Equity Shares Up To 13 Billion Rupees
Brief: Natco Pharma Board To Consider Fund Raising Via Equity Shares Or Securities
Brief: Natco Pharma Investing $14 Million In Egenesis Via Units
JSC NatCo KazakTemir JSC Nat.Co. Kaz-XY82 - Integrated Annual Report
Brief: Natco Pharma Declares Q1 Interim Dividend Of 1.50 Rupee Per Equity Share
Brief: Natco Pharma June-Quarter Consol Net Profit 2.07 Billion Rupees
Brief: Natco Pharma To Consider Fund Raising Via Equity Or Other Securities
India's Natco Pharma rises on tentative US nod for cancer drug generic
Brief: Natco Pharma Approves Investment Up To 14 Billion Rupees In Wholly Owned Subsidiary In South Africa
Brief: Natco Pharma March-Quarter Consol Net Profit 2.68 Billion Rupees
Brief: Natco Pharma Gets Demand Of 49.2 Million Rupees From National Pharmaceutical Pricing Authority
Brief: Natco Pharma To Incorporate Wholly Owned Subsidiary In Nigeria With Investment Up To $100,000
Factbox: Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
Analysts upbeat on semaglutide opportunity as patent expiry triggers India generics
Brief: Natco Pharma Launches Semaglutide Generic Injection Multi Dose Vials In India